Baupost Group - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baupost Group ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$203,700,000
+53.3%
15,000,000
-14.4%
2.54%
+29.7%
Q1 2020$132,862,000
+7.4%
17,527,968
-10.4%
1.96%
+43.6%
Q4 2019$123,692,000
+28.9%
19,571,453
-20.0%
1.37%
+25.8%
Q3 2019$95,928,000
-19.0%
24,471,4530.0%1.09%
+1.3%
Q2 2019$118,442,000
-40.9%
24,471,4530.0%1.07%
-36.3%
Q1 2019$200,421,000
+48.1%
24,471,4530.0%1.68%
+43.4%
Q4 2018$135,327,00024,471,4531.17%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 16,205,119$18,473,83631.57%
ACADIAN ASSET MANAGEMENT LLC 7,223,488$8,2330.04%
Orchard Capital Management, LLC 66,826$76,1820.03%
XTX Topco Ltd 138,506$157,8970.03%
State of Wyoming 74,010$84,3710.02%
WEALTH EFFECTS LLC 29,500$33,6300.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,719,061$1,959,7300.01%
James J. Burns & Company, LLC 24,542$280.01%
Eudaimonia Partners, LLC 27,144$30,9450.01%
SYKON CAPITAL LLC 15,000$17,1000.01%
View complete list of AKEBIA THERAPEUTICS INC shareholders